[1] Yang Q, Wang W, Liu C, et al. Effect of PFOS on glucocorticoid-induced changes in human decidual stromal cells in the first trimester of pregnancy. Reprod Toxicol, 2016; 63, 142-50. doi:  10.1016/j.reprotox.2016.06.003
[2] Olsen GW, Burris JM, Ehresman DJ, et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesul-fonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect, 2007; 115, 1298-305. doi:  10.1289/ehp.10009
[3] Li X, Ye L, Ge Y, et al. In utero perfluorooctane sulfonate exposure causes low body weights of fetal rats:A mechanism study. Placenta, 2016; 39, 125-33. doi:  10.1016/j.placenta.2016.01.010
[4] Zhang C, Wang C, Jia Z, et al. Differentially expressed mRNAs, lncRNAs, and miRNAs with associated co-expression and ceRNA networks in ankylosing spondylitis. Oncotarget, 2017; 8, 113543-57. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768345/
[5] Fuentes S, Colomina MT, Rodriguez J, et al. Interactions in developmental toxicology:concurrent exposure to perfluorooctane sulfonate (PFOS) and stress in pregnant mice. Toxicol Lett, 2006; 164, 81-9. doi:  10.1016/j.toxlet.2005.11.013
[6] Negri E, Metruccio F, Guercio V, et al. Exposure to PFOA and PFOS and fetal growth:a critical merging of toxicological and epidemiological data. Crit Rev Toxicol, 2017; 47, 482-508. doi:  10.1080/10408444.2016.1271972
[7] Bolehovska P, Sehnal B, Driak D, et al. Changes in placental angiogenesis and their correlation with foetal intrauterine restriction. Ceska Gynekol, 2015; 80, 144-50. http://europepmc.org/abstract/MED/25944605
[8] Ng YS, Krilleke D, Shima DT. VEGF function in vascular pathogenesis. Exp Cell Res, 2006; 312, 527-37. doi:  10.1016/j.yexcr.2005.11.008
[9] Weakley SM, Wang H, Yao Q, et al. Expression and function of a large non-coding RNA gene XIST in human cancer. World J Surg, 2011; 35, 1751-6. doi:  10.1007/s00268-010-0951-0
[10] Sene Lde B, Mesquita FF, de Moraes LN, et al. Involvement of renal corpuscle microRNA expression on epithelial-to-mesenchymal transition in maternal low protein diet in adult programmed rats. PloS One, 2013; 8, 71310. doi:  10.1371/journal.pone.0071310
[11] Cheng Z, Li Z, Ma K, et al. Long Non-coding RNA XIST Promotes Glioma Tumorigenicity and Angiogenesis by Acting as a Molecular Sponge of miR-429. J Cancer, 2017; 8, 4106-16. doi:  10.7150/jca.21024
[12] Chen D, Li Y, Li Y, et al. Tumor suppressive microRNA429 regulates cellular function by targeting VEGF in clear cell renal cell carcinoma. Mol Med Report, 2016; 13, 1361-6. doi:  10.3892/mmr.2015.4653